KRASG12C‐inhibitor‐based combination therapies for pancreatic cancer: insights from drug screening.

Autor: Tapia Contreras, Constanza¹ (AUTHOR), Falke, Jonas Dominik¹ (AUTHOR), Seifert, Dana‐Magdalena¹ (AUTHOR), Schneider, Carolin¹ (AUTHOR), Krauß, Lukas¹ (AUTHOR), Fang, Xin¹ (AUTHOR), Müller, Denise² (AUTHOR), Demirdizen, Engin¹ (AUTHOR), Spitzner, Melanie¹ (AUTHOR), De Oliveira, Tiago¹ (AUTHOR), Schneeweis, Christian³ (AUTHOR), Gaedcke, Jochen^1,4 (AUTHOR), Kaulfuß, Silke^4,5 (AUTHOR), Mirzakhani, Kimia^4,5 (AUTHOR), Wollnik, Bernd^4,5,6 (AUTHOR), Conrads, Karly^4,7 (AUTHOR), Beißbarth, Tim^4,7,8,9 (AUTHOR), Salinas, Gabriela^4,10 (AUTHOR), Hügel, Jonas^4,11 (AUTHOR), Beyer, Nils^4,11 (AUTHOR)

Publikováno v: Molecular Oncology. Sep2024, p1. 16p. 5 Illustrations.